{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:29:55Z","timestamp":1794490195393,"version":"4.9.1"},"reference-count":55,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1158210"],"award-info":[{"award-number":["1158210"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease. Definitive diagnosis of the progressive form, non-alcoholic steatohepatitis (NASH), requires liver biopsy, which is highly invasive and unsuited to early disease or tracking changes. Inadequate performance of current minimally invasive tools is a critical barrier to managing NAFLD burden. Altered circulating miRNA profiles show potential for minimally invasive tracking of NAFLD. The selective isolation of the circulating extracellular vesicle subset that originates from hepatocytes presents an important opportunity for improving the performance of miRNA biomarkers of liver disease. The expressions of miR-122, -192, and -128-3p were quantified in total cell-free RNA, global EVs, and liver-specific EVs from control, NAFL, and NASH subjects. In ASGR1+ EVs, each miR biomarker trended positively with disease severity and expression was significantly higher in NASH subjects compared with controls. The c-statistic defining the performance of ASGR1+ EV derived miRNAs was invariably &gt;0.78. This trend was not observed in the alternative sources. This study demonstrates the capacity for liver-specific isolation to transform the performance of EV-derived miRNA biomarkers for NAFLD, robustly distinguishing patients with NAFL and NASH.<\/jats:p>","DOI":"10.3390\/biomedicines10010195","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T20:46:03Z","timestamp":1642452363000},"page":"195","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3303-1666","authenticated-orcid":false,"given":"Lauren A.","family":"Newman","sequence":"first","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivile","family":"Useckaite","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Johnson","sequence":"additional","affiliation":[{"name":"Early Clinical Development, Pfizer Global Research and Development, Groton, CT 06340, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-866X","authenticated-orcid":false,"given":"Michael J.","family":"Sorich","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7652-4378","authenticated-orcid":false,"given":"Ashley M.","family":"Hopkins","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rowland","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fmed.2020.00395","article-title":"Insights into extracellular vesicles as biomarker of NAFLD pathogenesis","volume":"7","author":"Alen","year":"2020","journal-title":"Front. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-med-051215-031109","article-title":"Nonalcoholic steatohepatitis","volume":"68","author":"Suzuki","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/gutjnl-2017-315691","article-title":"Non-alcoholic steatohepatitis pathogenesis: Sublethal hepatocyte injury as a driver of liver inflammation","volume":"67","author":"Ibrahim","year":"2018","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: Results from a nationwide cohort","volume":"70","author":"Simon","year":"2020","journal-title":"Gut"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"Cusi","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31869","DOI":"10.1038\/srep31869","article-title":"Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats","volume":"6","author":"Castoldi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Newman, L.A., Sorich, M.J., and Rowland, A. (2020). Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072032"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dongiovanni, P., Meroni, M., Longo, M., Fargion, S., and Fracanzani, A.L. (2018). miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123966"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Endzeli\u0146\u0161, E., Berger, A., Melne, V., Bajo-Santos, C., Sobo\u013cevska, K., \u0100bols, A., Rodriguez, M., \u0160antare, D., Rud\u0146ickiha, A., and Lietuvietis, V. (2017). Detection of circulating miRNAs: Comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3737-z"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"00079","DOI":"10.3389\/fmolb.2017.00079","article-title":"Technical advances to study extracellular vesicles","volume":"4","year":"2017","journal-title":"Front. Mol. Biosci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Newman, L., Fahmy, A., Sorich, M., Best, O., Rowland, A., and Useckaite, Z. (2021). Importance of between and within subject variability in extracellular vesicle abundance and cargo when performing biomarker analyses. Cells, 10.","DOI":"10.3390\/cells10030485"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/cpt.1328","article-title":"From Endogenous Compounds as Biomarkers to Plasma-Derived Nanovesicles as Liquid Biopsy; Has the Golden Age of Translational Pharmacokinetics-Absorption, Distribution, Metabolism, Excretion-Drug\u2013Drug Interaction Science Finally Arrived?","volume":"105","author":"Rodrigues","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3389\/fphar.2019.01500","article-title":"Non-exosomal and exosomal circulatory micrornas: Which are more valid as biomarkers?","volume":"10","author":"Kamal","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra1704286","article-title":"Circulating extracellular vesicles in human disease","volume":"379","author":"Shah","year":"2018","journal-title":"NEJM"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xin, S., Zhan, Q., Chen, X., Xu, J., and Yu, Y. (2020). Efficacy of serum miRNA test as a non-invasive method to diagnose nonalcoholic steatohepatitis: A systematic review and meta-analysis. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01334-8"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"Mestdagh","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cpt.2244","article-title":"Exploring the use of serum-derived small extracellular vesicles as liquid biopsy to study the induction of hepatic cytochromes P450 and organic anion transporting polypeptides","volume":"110","author":"Rodrigues","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1038\/emm.2017.288","article-title":"Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer","volume":"50","author":"Poel","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1286095","DOI":"10.1080\/20013078.2017.1286095","article-title":"Obstacles and opportunities in the functional analysis of extracellular vesicle RNA\u2014An ISEV position paper","volume":"6","author":"Mateescu","year":"2017","journal-title":"J. Extracell. Vesicles"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bib\/bbv056","article-title":"Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR","volume":"17","author":"Marabita","year":"2016","journal-title":"Briefings Bioinform."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Witwer","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: From pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal MicroRNA 192-5p activates macrophages through Rictor\/Akt\/Forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2012.09.024","article-title":"Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells","volume":"58","author":"Noetel","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s13105-018-0625-1","article-title":"miR-128-3p regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2","volume":"74","author":"Chen","year":"2018","journal-title":"J. Physiol. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16699","DOI":"10.1038\/s41598-018-35139-3","article-title":"A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer","volume":"8","author":"Pan","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-019-0981-7","article-title":"Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1499-3872(16)60098-X","article-title":"Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles","volume":"16","author":"Zhang","year":"2017","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3892\/or.2015.3936","article-title":"miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients","volume":"33","author":"Huang","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tibs.2021.01.007","article-title":"Extracellular miRNAs and Cell\u2013Cell Communication: Problems and prospects","volume":"46","author":"Makarova","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref_38","first-page":"e89631","article-title":"Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients","volume":"1","author":"Zijlstra","year":"2016","journal-title":"JCI Insight"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.3892\/mmr.2021.12137","article-title":"Circulating microRNA-135a-3p in serum extracellular vesicles as a potential biological marker of non-alcoholic fatty liver disease","volume":"24","author":"Jiang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fnins.2017.00278","article-title":"Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes","volume":"11","author":"Mustapic","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00401-014-1314-y","article-title":"Plasma exosomal \u03b1-synuclein is likely CNS-derived and increased in Parkinson\u2019s disease","volume":"128","author":"Shi","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1096\/fj.201600816R","article-title":"Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1096\/fj.201700149","article-title":"Altered cargo proteins of human plasma endothelial cell\u2013derived exosomes in atherosclerotic cerebrovascular disease","volume":"31","author":"Goetzl","year":"2017","journal-title":"FASEB J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32299","DOI":"10.1038\/srep32299","article-title":"Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines","volume":"6","author":"Gotanda","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/hep4.1556","article-title":"Characterization and proteome of circulating extracellular vesicles as potential biomarkers for NASH","volume":"4","author":"Povero","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.3980","article-title":"Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis","volume":"21","author":"Wagschal","year":"2015","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-\u03b3","volume":"1","author":"Povero","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/embr.201541930","article-title":"Reversible HuR-micro RNA binding controls extracellular export of miR-122 and augments stress response","volume":"17","author":"Mukherjee","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2006.04.031","article-title":"Relief of microRNA-Mediated translational repression in human cells subjected to stress","volume":"125","author":"Bhattacharyya","year":"2006","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Povero, D., Eguchi, A., Li, H., Johnson, C.D., Papouchado, B.G., Wree, A., Messer, K., and Feldstein, A.E. (2014). Circulating extracellular vesicles with specific proteome and liver micrornas are potential biomarkers for liver injury in experimental fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113651"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: From serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating MicroRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.3748\/wjg.v22.i44.9844","article-title":"Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population","volume":"22","author":"Liu","year":"2016","journal-title":"World J. Gastroenterol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/1\/195\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:02:48Z","timestamp":1760133768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/1\/195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["biomedicines10010195"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10010195","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]}}}